Efficacy of outcome prediction of the respiratory ECMO survival prediction score and the predicting death for severe ARDS on VV-ECMO score for patients with acute respiratory distress syndrome on extracorporeal membrane oxygenation.
Gavin Majithia-BeetRoozbeh NaemiRichard W IssittPublished in: Perfusion (2022)
It was the findings of this review, indicated by analysis using the AUROC measures, that the prognostic model PRESERVE performed better than RESP for predicting post ECMO therapy outcomes, for patients presenting with Acute Respiratory Distress Syndrome within their respective validated time frames, i.e., RESP at Intensive care unit (ICU) discharge and PRESERVE at 6 months post ICU discharge. However, It was recognized that comparator groups were small thereby introducing bias into the study. Further prospective, randomized studies would be necessary to effectively assess the utility of these predictive survival scores.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- intensive care unit
- respiratory failure
- free survival
- open label
- double blind
- randomized controlled trial
- placebo controlled
- stem cells
- phase iii
- early onset
- skeletal muscle
- metabolic syndrome
- cell therapy
- respiratory tract
- case control
- drug induced